Inhalation Anesthesia Market Outlook 2024 : Expected Market Growth Rate, Major Driver And Segments | Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation

"The new report published by The Business Research Company, titled ""Inhalation Anesthesia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the inhalation anesthesia market size has grown strongly in recent years. It will grow from $1.46 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The inhalation anesthesia market size is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=7198&type=smp

Rising Geriatric Population Driving Growth In The Inhalation Anesthesia Market
The increasing geriatric population is anticipated to propel the growth of inhalation anesthesia during the forecast period. The increasing geriatric population is boosting the inhalation anesthesia market as they are highly prone to degenerative diseases and chronic illnesses, which eventually leads to a rise in surgeries and therapeutics. Moreover, the increasing geriatric population, which is more susceptible to ailments, such as cardiovascular, neurological, respiratory, and degenerative disorders, is boosting the market growth. It is usually inconvenient to administer anesthesia through an intravenous route to geriatric patients due to punctured blood vessels and issues with patient compliance. For instance, in October 2022, according to the World Health Organization, a Switzerland-based international public health organization, the global population of individuals aged 60 years is projected to increase to 1.4 billion by 2022 compared to 1 billion in 2020. Moreover, 1 out of 6 people in the world will be aged more than 60 years or older by 2030. Therefore, the increasing geriatric population is expected to boost demand for inhalation anesthesia during the forecast period.

Sedaconda's Global Expansion And Impact On Inhalation Anesthesia
Many companies operating in inhalation anesthesia are developing innovative products such as Sedaconda to meet industry demands and strengthen the market position across the globe. Sedaconda is an inhaled sedation therapy delivered using the Anaesthetic Conserving Device (ACD) and approved for use in intensive care. For instance, in February 2022, Sedana Medical AB, a Sweden based med tech and pharmaceutical company introduced Sedaconda (isoflurane) to the German market. Sedaconda (isoflurane) is delivered using the medical device known as Sedaconda ACD (Anaesthetic Conserving Device) and is the sole approved inhaled sedation therapy authorized for use in intensive care settings. Following the European DCP approval in July 2021, Sedaconda (isoflurane) has received national approvals in 14 countries.

The inhalation anesthesia market covered in this report is segmented -

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide
2) By Application: Induction, Maintenance
3) By End User: Hospitals, Ambulatory Surgical Centers

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=7198&type=discount

Major companies operating in the inhalation anesthesia market report are Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

Contents of the report:
1. Executive Summary
2. Inhalation Anesthesia Market Report Structure
3. Inhalation Anesthesia Market Trends And Strategies
4. Inhalation Anesthesia Market - Macro Economic Scenario
5. Inhalation Anesthesia Market Size And Growth
…..
27. Inhalation Anesthesia Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.